Legend Biotech CorporationLEGNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank73
3Y CAGR-33.7%
5Y CAGR-4.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-33.7%/yr
vs -0.9%/yr prior
5Y CAGR
-4.3%/yr
Recent deceleration
Acceleration
-32.9pp
Decelerating
Percentile
P73
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 15.10% |
| Q2 2025 | -3.55% |
| Q1 2025 | -2.40% |
| Q4 2024 | 9.33% |
| Q3 2024 | -15.19% |
| Q2 2024 | 11.55% |
| Q1 2024 | -4.47% |
| Q4 2023 | 10.25% |
| Q3 2023 | 0.07% |
| Q2 2023 | 12.84% |
| Q1 2023 | 5.12% |
| Q4 2022 | -22.73% |
| Q3 2022 | 51.85% |
| Q2 2022 | -15.39% |
| Q1 2022 | -5.96% |
| Q4 2021 | 19.62% |
| Q3 2021 | -13.35% |
| Q2 2021 | 17.43% |
| Q1 2021 | 6.18% |
| Q4 2020 | 5.15% |
| Q3 2020 | 18.83% |
| Q2 2020 | 11.59% |
| Q1 2020 | -27.37% |
| Q4 2019 | 57.69% |
| Q3 2019 | 28.42% |
| Q2 2019 | 53.32% |
| Q1 2019 | 0.00% |